These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21311178)

  • 1. Androgen receptor mutations are associated with altered epigenomic programming as evidenced by HOXA5 methylation.
    Bens S; Ammerpohl O; Martin-Subero JI; Appari M; Richter J; Hiort O; Werner R; Riepe FG; Siebert R; Holterhus PM
    Sex Dev; 2011; 5(2):70-6. PubMed ID: 21311178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of Homeobox A5 gene in nonsmall cell lung cancer and its relationship with clinicopathological features.
    Kim DS; Kim MJ; Lee JY; Lee SM; Choi JY; Yoon GS; Na YK; Hong HS; Kim SG; Choi JE; Lee SY; Park JY
    Mol Carcinog; 2009 Dec; 48(12):1109-15. PubMed ID: 19554572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
    Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
    Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight novel mutations of the androgen receptor gene in patients with androgen insensitivity syndrome.
    Chávez B; Méndez JP; Ulloa-Aguirre A; Larrea F; Vilchis F
    J Hum Genet; 2001; 46(10):560-5. PubMed ID: 11587068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cells.
    Jarrard DF; Kinoshita H; Shi Y; Sandefur C; Hoff D; Meisner LF; Chang C; Herman JG; Isaacs WB; Nassif N
    Cancer Res; 1998 Dec; 58(23):5310-4. PubMed ID: 9850055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).
    Hornig NC; Rodens P; Dörr H; Hubner NC; Kulle AE; Schweikert HU; Welzel M; Bens S; Hiort O; Werner R; Gonzalves S; Eckstein AK; Cools M; Verrijn-Stuart A; Stunnenberg HG; Siebert R; Ammerpohl O; Holterhus PM
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4617-4627. PubMed ID: 30124873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete androgen insensitivity without Wolffian duct development: the AR-A form of the androgen receptor is not sufficient for male genital development.
    Barbaro M; Oscarson M; Almskog I; Hamberg H; Wedell A
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):822-6. PubMed ID: 17408421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The androgen receptor gene is preferentially hypermethylated in follicular non-Hodgkin's lymphomas.
    Yang H; Chen CM; Yan P; Huang TH; Shi H; Burger M; Nimmrich I; Maier S; Berlin K; Caldwell CW
    Clin Cancer Res; 2003 Sep; 9(11):4034-42. PubMed ID: 14519624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell renal cell carcinoma.
    Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
    Pathol Int; 2010 Oct; 60(10):661-6. PubMed ID: 20846263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.
    Kinoshita H; Shi Y; Sandefur C; Meisner LF; Chang C; Choon A; Reznikoff CR; Bova GS; Friedl A; Jarrard DF
    Cancer Res; 2000 Jul; 60(13):3623-30. PubMed ID: 10910077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation in the androgen receptor gene promoter region in rat prostate cancers.
    Takahashi S; Inaguma S; Sakakibara M; Cho YM; Suzuki S; Ikeda Y; Cui L; Shirai T
    Prostate; 2002 Jun; 52(1):82-8. PubMed ID: 11992622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic setting for long-term expression of estrogen receptor α and androgen receptor in cells.
    Imamura T
    Horm Behav; 2011 Mar; 59(3):345-52. PubMed ID: 20619266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the amino-terminal domain of the human androgen receptor may be associated with partial androgen insensitivity and impaired transactivation in vitro.
    Holterhus PM; Werner R; Struve D; Hauffa BP; Schroeder C; Hiort O
    Exp Clin Endocrinol Diabetes; 2005 Sep; 113(8):457-63. PubMed ID: 16151980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel androgen receptor gene mutations in Australian patients with complete androgen insensitivity syndrome.
    MacLean HE; Ball EM; Rekaris G; Warne GL; Zajac JD
    Hum Mutat; 2004 Mar; 23(3):287. PubMed ID: 14974091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global leukocyte DNA methylation is not altered in euthymic bipolar patients.
    Bromberg A; Bersudsky Y; Levine J; Agam G
    J Affect Disord; 2009 Nov; 118(1-3):234-9. PubMed ID: 19269035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.
    Appari M; Werner R; Wünsch L; Cario G; Demeter J; Hiort O; Riepe F; Brooks JD; Holterhus PM
    J Mol Med (Berl); 2009 Jun; 87(6):623-32. PubMed ID: 19330472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered transcription profiles of key-enzymes of androgen biosynthesis in genital skin fibroblasts from patients with 46,XY disorders of sex development (DSD).
    Hoppe U; Wünsch L; Holterhus PM; Jocham D; Richter-Unruh A; Hiort O
    Sex Dev; 2007; 1(4):230-7. PubMed ID: 18391534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor expression in androgen-independent prostate cancer cell lines.
    Chlenski A; Nakashiro K; Ketels KV; Korovaitseva GI; Oyasu R
    Prostate; 2001 Apr; 47(1):66-75. PubMed ID: 11304731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutation in the ligand-binding domain of the androgen receptor gene (l790p) associated with complete androgen insensitivity syndrome.
    Raicu F; Giuliani R; Gatta V; Palka C; Franchi PG; Lelli-Chiesa P; Tumini S; Stuppia L
    Asian J Androl; 2008 Jul; 10(4):687-91. PubMed ID: 18097502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.